{"abstract": "Charles River Laboratories said Monday that it had agreed to acquire WuXi Pharma Tech, a Chinese pharmaceutical outsourcing services provider, in a cash and stock deal worth $1.6 billion.", "web_url": "https://dealbook.nytimes.com/2010/04/26/charles-river-buys-chinese-drug-research-firm/", "snippet": "Charles River Laboratories said Monday that it had agreed to acquire WuXi Pharma Tech, a Chinese pharmaceutical outsourcing services provider, in a cash and stock deal worth $1.6 billion.", "lead_paragraph": "Charles River Laboratories said Monday that it had agreed to acquire WuXi Pharma Tech, a Chinese pharmaceutical outsourcing services provider, in a cash and stock deal worth $1.6 billion, David Barboza and Michael J. de la Merced reported in The New York Times.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Charles River Buys Chinese Drug Research Firm", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Charles River Laboratories", "rank": 1, "major": "N"}, {"name": "organizations", "value": "New York Stock Exchange", "rank": 2, "major": "N"}, {"name": "glocations", "value": "China", "rank": 3, "major": "N"}], "pub_date": "2010-04-26T11:26:12+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/9b94feed-8e52-5865-a5ad-d1ab0c3ee82e", "word_count": 388, "uri": "nyt://article/9b94feed-8e52-5865-a5ad-d1ab0c3ee82e"}